S90652 in Paediatric Hypertension

Servier

Status and phase: Completed; Phase 2

Conditions: Hypertension

Treatments: Drug: Perindopril

Study type: Interventional

Funder types: Other

Identifiers

NCT00202592

CL2-90652-002

Details and patient eligibility

About

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children

Enrollment: 50 estimated patients

Sex: All

Ages: 30 months to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy

Exclusion criteria

• Poorly controlled hypertension
• Girls with signs of pubescence